Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOP STORY—E.D. Tex.: $340M was sufficient disgorgement for attempted monopolization of safety syringes
    • ADVERTISING NEWS: Ads for vegan mayonnaise alternative alleged to deceive consumers
    • ADVERTISING—D.N.J.: Bayer may be liable for “bloated” probiotics claims
    • ADVERTISING—N.D. Cal.: Payment processor’s false ad claims dropped for lack of particularity
    • AGENCY NEWS: ACCC Chairman promotes economic reforms for Australian competition policy
    • ANTITRUST NEWS: AAI urges FTC to carefully scrutinize CVS co-pay policy
    • ANTITRUST NEWS: Five banks to pay $4.3 billion in global settlement for attempted forex manipulation
    • ANTITRUST—E.D. La.: Dentist’s claims against state board for license revocation fail
    • ANTITRUST—E.D. Mo.: Former bank affiliate employee could not sue for tying arrangement targeting customer
    • FRANCHISING & DISTRIBUTION—W.D.N.C.: Franchisees’ claims against franchisor subject to arbitration
    • LAW FIRM NEWS: BakerHostetler adds Melinda McLellan to privacy practice
    • PRIVACY—9th Cir.: Sirius XM Radio arbitration provision deemed unenforceable
    • RICO—D. Mass.: Neurontin class attorneys awarded 28% of settlement fund
    • SUPREME COURT DOCKET: Recent decisions, cases, and petitions pending High Court review
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Antitrust Law Daily Wrap Up, ANTITRUST NEWS: AAI urges FTC to carefully scrutinize CVS co-pay policy, (Nov 12, 2014)

    Organizations Mentioned:American Antitrust Institute | CVS Health

    By Greg Hammond, J.D.

    The American Antitrust Institute (AAI) is requesting that the FTC carefully scrutinize CVS Health Corp.’s newly announced policy, imposing an increased co-pay on consumers who use health insurance to fill prescriptions at pharmacies that sell ...

    By Greg Hammond, J.D.

    The American Antitrust Institute (AAI) is requesting that the FTC carefully scrutinize CVS Health Corp.’s newly announced policy, imposing an increased co-pay on consumers who use health insurance to fill prescriptions at pharmacies that sell cigarettes and other tobacco products. According to the advocacy group, the new policy could be an anticompetitive effort to exclude competing retail pharmacies, rather than an effort to end smoking and tobacco use.

    CVS made waves earlier this year by announcing that it would stop selling tobacco products in its stores. However, its latest policy allegedly will impose up to $15 higher co-pays every time a customer with CVS Caremark-administered insurance has a prescription filled by a pharmacy that also sells tobacco.

    “So let’s be clear. If your insurance company contracts with CVS Caremark to manage your drug benefits and you do not use CVS pharmacies, you will probably have to change pharmacies in order to avoid the penalty, if there is no ‘opt-out’ from the new, higher co-pay policy,” the AAI stated. “The upshot may be no effect on tobacco availability, but rather simply raising prices for consumers that shop at rival pharmacies.”

    The AAI also suggests that CVS’ new policy could be more dangerous for competition and consumers than any of the company’s previous conduct, noting that the markets in which CVS competes are becoming more concentrated each year, due to a “general laxness of antitrust enforcement” in this area.

    “Even if CVS’s new co-pay policy is motivated entirely by a desire to discourage smoking, CVS’s use of its market power to bludgeon consumers and rivals into ending tobacco sales at rival pharmacies is not a legitimate form of competition,” the group concluded.

    The American Antitrust Institute is an education, research, and advocacy organization located in Washington, D.C. Its stated mission is to increase the role of competition, assure that competition serves the interests of consumers, and challenge abuses of concentrated economic power in the American and world economy.

    Companies: American Antitrust Institute

    News: Antitrust IndustryNewsTrends

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use